Caxton Associates (New York)’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,843
Closed -$207K 466
2023
Q3
$207K Buy
+7,843
New +$207K 0.03% 354